Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Shuai Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-4305-9806; OpenAlex author ID A5110256820. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 10

  1. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Co-author DOI 10.1038/s41388-021-01960-w↗
  2. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-18-0419↗
  3. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Co-author DOI 10.1038/s41388-017-0082-2↗
  4. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Co-author DOI 10.1038/s41388-018-0382-1↗
  5. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Co-author DOI 10.1038/s41419-017-0158-5↗
  6. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway. Co-author DOI 10.1038/cddis.2017.189↗
  7. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. Co-author DOI 10.1158/1535-7163.mct-15-0877↗
  8. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. First author DOI 10.1016/j.canlet.2014.08.007↗
  9. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Co-author DOI 10.1158/1535-7163.mct-13-0296↗
  10. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. Co-author DOI 10.1371/journal.pone.0073803↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Zhao · 10 shared papers, 2013–2021 · strength 0.61
  2. Chunyou Wang · 10 shared papers, 2013–2021 · strength 0.61
  3. Shichang Deng · 9 shared papers, 2013–2019 · strength 0.50
  4. Shi-Jiang Deng · 7 shared papers, 2014–2019 · strength 0.44
  5. Zhu Zeng · 5 shared papers, 2016–2021 · strength 0.37
  6. Xiang Li · 7 shared papers, 2013–2018 · strength 0.35
  7. Mingliang Liu · 5 shared papers, 2016–2019 · strength 0.34
  8. Ye Zeng · 4 shared papers, 2018–2021 · strength 0.32
  9. Yan Jin · 5 shared papers, 2014–2018 · strength 0.29
  10. Fengyu Xu · 3 shared papers, 2018–2021 · strength 0.25
  11. Qi Qin · 4 shared papers, 2013–2018 · strength 0.17
  12. Qiang Li · 2 shared papers, 2018–2019 · strength 0.15
  13. Peng Xu · 1 shared paper, 2021 · strength 0.10
  14. Yuhang Hu · 1 shared paper, 2021 · strength 0.10
  15. Yi Niu · 1 shared paper, 2018 · strength 0.07
  16. Jungang Zhang · 2 shared papers, 2013 · strength 0.06
  17. Ming Yang · 1 shared paper, 2014 · strength 0.03
  18. Tao Yin · 1 shared paper, 2014 · strength 0.03
  19. Heshui Wu · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.